Suggested approaches for research protocols involving the potential for life-threatening reactionsDaniel L. Hamilos, Thomas Corbridge, John Oppenheimer et al.|Journal of Allergy and Clinical Immunology|1993Cited by 19
Nal-Iri and 5-FU/LV Compared to 5-FU/LV in Patients with Cholangio- and Gallbladder Carcinoma Previously Treated with Gemcitabine-Based Therapies: The AIO NALIRICC TrialArndt Vogel, Martha M. Kirstein, Gunnar Folprecht et al.|SSRN Electronic Journal|2024Cited by 0